Literature DB >> 31537108

A prospective study on osmophobia in migraine versus tension-type headache in a large series of attacks.

Alberto Terrin1, Federico Mainardi2, Carlo Lisotto3, Edoardo Mampreso4, Matteo Fuccaro5, Ferdinando Maggioni1, Giorgio Zanchin1.   

Abstract

BACKGROUND: In literature, osmophobia is reported as a specific migrainous symptom with a prevalence of up to 95%. Despite the International Classification of Headache Disorders 2nd edition proposal of including osmophobia among accompanying symptoms, it was no longer mentioned in the ICHD 3rd edition.
METHODS: We conducted a prospective study on 193 patients suffering from migraine without aura, migraine with aura, episodic tension-type headache or a combination of these. After a retrospective interview, each patient was asked to describe in detail osmophobia, when present, in the following four headache attacks.
RESULTS: In all, 45.7% of migraine without aura attacks were associated with osmophobia, 67.2% of migraineurs reported osmophobia in at least a quarter of the attacks. No episodic tension-type headache attack was associated with osmophobia. It was associated with photophobia or phonophobia in 4.3% of migraine without aura attacks, and it was the only accompanying symptom in 4.7% of migraine without aura attacks. The inclusion of osmophobia in the ICHD-3 diagnostic criteria would enable a 9.0% increased diagnostic sensitivity.
CONCLUSION: Osmophobia is a specific clinical marker of migraine, easy to ascertain and able to disentangle the sometimes challenging differential diagnosis between migraine without aura and episodic tension-type headache. We recommend its inclusion among the diagnostic criteria for migraine as it increases sensitivity, showing absolute specificity.

Entities:  

Keywords:  Primary headaches; diagnostic criteria; smell; trigger

Mesh:

Year:  2019        PMID: 31537108     DOI: 10.1177/0333102419877661

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  4 in total

1.  COVID-19-related headache and sinonasal inflammation: A longitudinal study analysing the role of acute rhinosinusitis and ICHD-3 classification difficulties in SARS-CoV-2 infection.

Authors:  Marcin Straburzyński; Magdalena Nowaczewska; Sławomir Budrewicz; Marta Waliszewska-Prosół
Journal:  Cephalalgia       Date:  2021-09-20       Impact factor: 6.292

2.  Interictal osmophobia is associated with longer migraine disease duration.

Authors:  Gudrun Gossrau; Marie Frost; Anna Klimova; Thea Koch; Rainer Sabatowski; Coralie Mignot; Antje Haehner
Journal:  J Headache Pain       Date:  2022-07-15       Impact factor: 8.588

Review 3.  Pathophysiology and Therapy of Associated Features of Migraine.

Authors:  Maria Dolores Villar-Martinez; Peter J Goadsby
Journal:  Cells       Date:  2022-09-05       Impact factor: 7.666

4.  The relevance of migraine in the clinical spectrum of mitochondrial disorders.

Authors:  Alberto Terrin; Luca Bello; Maria Lucia Valentino; Leonardo Caporali; Gianni Sorarù; Valerio Carelli; Ferdinando Maggioni; Massimo Zeviani; Elena Pegoraro
Journal:  Sci Rep       Date:  2022-03-10       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.